Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schols

Showing results (1-10 of 134) with videos related to

Pageof 14
Sort By:
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|September 29, 1999
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonistD Schols
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|March 26, 2003
[Role of chemokines in the HIV infection process]P Proost, D Schols
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
Development of new potent and selective agents against HIV (human immunodeficiency virus)R Pauwels, D Schols
Journal of Virology|August 1, 1996
Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 productionD Schols, E De Clercq
The Journal of General Virology|September 25, 1998
The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cellsD Schols, E De Clercq
Antiviral Chemistry & Chemotherapy|October 12, 2001
Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonistsE De Clercq, D Schols
Current Pharmaceutical Design|December 17, 2010
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilizationS Liekens, D Schols, S Hatse
Journal of Virology|August 17, 2001
No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1F A Koning, D Schols, H Schuitemaker
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administrationD Schols, D Jones, M G Roncarolo
Antiviral Research|September 10, 1999
Selective activity of various antiviral compounds against HHV-7 infectionY Zhang, D Schols, E De Clercq
Pageof 14

Showing results (1-10 of 134) with videos related to

Sort By:
Pageof 14
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|September 29, 1999
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonistD Schols
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|March 26, 2003
[Role of chemokines in the HIV infection process]P Proost, D Schols
Verhandelingen - Koninklijke Academie Voor Geneeskunde Van Belgie|January 1, 1991
Development of new potent and selective agents against HIV (human immunodeficiency virus)R Pauwels, D Schols
Journal of Virology|August 1, 1996
Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 productionD Schols, E De Clercq
The Journal of General Virology|September 25, 1998
The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cellsD Schols, E De Clercq
Antiviral Chemistry & Chemotherapy|October 12, 2001
Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonistsE De Clercq, D Schols
Current Pharmaceutical Design|December 17, 2010
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell mobilizationS Liekens, D Schols, S Hatse
Journal of Virology|August 17, 2001
No selection for CCR5 coreceptor usage during parenteral transmission of macrophagetropic syncytium-inducing human immunodeficiency virus type 1F A Koning, D Schols, H Schuitemaker
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1995
Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administrationD Schols, D Jones, M G Roncarolo
Antiviral Research|September 10, 1999
Selective activity of various antiviral compounds against HHV-7 infectionY Zhang, D Schols, E De Clercq
Pageof 14